Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment-Reference-Cited by-同舟云学术

Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment

Published:2018-01-01 Issue:1 Volume:25 Page:461-471
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Zhang Baozhen¹,Cheng Guogang¹,Zheng Mingbin²,Han Jinyu¹,Wang Baobei¹,Li Mengxia¹,Chen Jie¹,Xiao Tianxia¹,Zhang Jian¹,Cai Lintao²,Li Shoujun³⁴,Fan Xiujun¹^ORCID

Affiliation:

1. Laboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China;

2. Guangdong Key Laboratory of Nanomedicine, CAS Key Lab for Health Informatics, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China;

3. Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases, Guangzhou, China;

4. College of Veterinary Medicine, South China Agricultural University, Guangzhou, China

Funder

National Key R&D Program of China

National Natural Science Foundation

Natural Science Foundation of Guangdong Province

Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Disease

Shenzhen Basic Research Fund

Public Welfare Project of Guangdong Province

Natural Science Foundation

Shenzhen Science and Technology Program

Publisher